WhiteLab Genomics
PrivateLast Round
Series B
Oct 6, 2026
Total Funding Raised
$46.54M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
WhiteLab Genomics is a biotechnology company that provides an AI-powered platform to accelerate and de-risk the design and development of gene, cell, and RNA therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WhiteLab Genomics Comparables
Compare WhiteLab Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Form Bio | 84% | |
| Dyno Therapeutics | 82% | |
| Lir Therapeutics | 81% |
WhiteLab Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 6, 2026 | ||||
| Early Funding | Jan 30, 2025 | ||||
| Series A | Sep 13, 2022 | ||||
| Accelerator | Jan 1, 2022 | ||||
| Grant | Jul 9, 2019 |
WhiteLab Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Blast.club | Series B |
| Atlantic Vantage Point | Series B |
| EIT Health | Grant |
| Y Combinator | Accelerator, Series A |
| Omnes Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 6, 2026
$26M round led by Atlantic Vantage Point.
- Jul 24, 2026
Monthly visitors grew 31% MoM, reaching 4.4K.
Recent news
Latest coverage and updates
- partners_withOct 6, 2026
WhiteLab Genomics, Inc. partners with Institut Imagine
- partners_withOct 6, 2026
WhiteLab Genomics, Inc. partners with Cytiva
- hiresOct 6, 2026
WhiteLab Genomics, Inc. will add Daniel Teper to its Board of Directors
- partners_withOct 6, 2026
WhiteLab Genomics, Inc. partners with Paris Brain Institute on genomic medicine research
- partners_withOct 6, 2026
WhiteLab Genomics, Inc. partners with Sanofi
WhiteLab Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about WhiteLab Genomics's valuation, stock price, and market status.
Is WhiteLab Genomics a public or private company?
WhiteLab Genomics is a private company.
What is the current stock price of WhiteLab Genomics?
WhiteLab Genomics is a private company with no public stock price. No recent secondary market data is available.
How much is WhiteLab Genomics worth (valuation)?
Valuation information for WhiteLab Genomics is not publicly available.
Can I buy WhiteLab Genomics stock?
WhiteLab Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was WhiteLab Genomics's last funding round?
WhiteLab Genomics's most recent funding round was Early Funding on January 30, 2025.
Who are the main investors in WhiteLab Genomics?
Key investors in WhiteLab Genomics include Omnes Capital.
Will WhiteLab Genomics IPO soon?
No public IPO plans have been announced for WhiteLab Genomics.
How can I track WhiteLab Genomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor WhiteLab Genomics's secondary market activity and sign up for updates.